BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15065764)

  • 1. NKG2D.
    Lanier LL
    J Biol Regul Homeost Agents; 2003; 17(4):338-40. PubMed ID: 15065764
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A.
    Wolan DW; Teyton L; Rudolph MG; Villmow B; Bauer S; Busch DH; Wilson IA
    Nat Immunol; 2001 Mar; 2(3):248-54. PubMed ID: 11224525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D and Related Immunoreceptors.
    Strong RK; McFarland BJ
    Adv Protein Chem; 2004; 68():281-312. PubMed ID: 15500864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.
    Zhang B; Wei H; Zheng X; Zhang J; Sun R; Tian Z
    Peptides; 2005 Mar; 26(3):405-12. PubMed ID: 15652646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway.
    Horng T; Bezbradica JS; Medzhitov R
    Nat Immunol; 2007 Dec; 8(12):1345-52. PubMed ID: 17952078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell signaling pathways.
    Vivier E; Nunès JA; Vély F
    Science; 2004 Nov; 306(5701):1517-9. PubMed ID: 15567854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte associated Ig-like receptor (LAIR).
    Meyaard L
    J Biol Regul Homeost Agents; 2003; 17(4):330-3. PubMed ID: 15065762
    [No Abstract]   [Full Text] [Related]  

  • 8. NKG2D ligands: key targets of the immune response.
    González S; López-Soto A; Suarez-Alvarez B; López-Vázquez A; López-Larrea C
    Trends Immunol; 2008 Aug; 29(8):397-403. PubMed ID: 18602338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells.
    Baeriswyl V; Wodnar-Filipowicz A; Kalberer CP
    Haematologica; 2006 Nov; 91(11):1538-41. PubMed ID: 17043026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the NKG2D receptor for tumor immunity.
    Coudert JD; Held W
    Semin Cancer Biol; 2006 Oct; 16(5):333-43. PubMed ID: 16914326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential NKG2D binding to highly related human NKG2D ligands ULBP2 and RAET1G is determined by a single amino acid in the alpha2 domain.
    Wittenbrink M; Spreu J; Steinle A
    Eur J Immunol; 2009 Jun; 39(6):1642-51. PubMed ID: 19424970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
    Savithri B; Khar A
    Eur J Immunol; 2006 Jan; 36(1):107-17. PubMed ID: 16323246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NKG2D receptor: sensing stressed cells.
    López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
    Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
    Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.
    Chalupny NJ; Rein-Weston A; Dosch S; Cosman D
    Biochem Biophys Res Commun; 2006 Jul; 346(1):175-81. PubMed ID: 16750166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of natural killer cells: underlying molecular mechanisms revealed.
    Backström E; Kristensson K; Ljunggren HG
    Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2D ligands in tumor immunity.
    Nausch N; Cerwenka A
    Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
    Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRTH2.
    Nagata K
    J Biol Regul Homeost Agents; 2003; 17(4):334-7. PubMed ID: 15065763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.